$ cat ./records/committed-258-3-million-for-malaria-research-and-development-one--2005.txt
Committed $258.3 million for malaria research and development — one of the largest ever private malaria investments
[RECORD.TXT] · cat --full
The Gates Foundation committed $258.3 million for malaria research and development in 2005 — one of the largest single private investments in malaria ever made. The funding supported vaccine development, new drug discovery, insecticide research, and improved diagnostics. Gates argued that malaria was one of the most solvable large-scale health problems given that the parasite had already been eradicated from Europe and North America in the twentieth century, and that the remaining burden was concentrated in low-income countries that lacked the resources to apply existing interventions at scale.
Source: https://www.gatesfoundation.org/our-work/programs/global-health/malaria
Free forever · No ads · Solo developer
If this was worth a read, help make the next entry possible.
Every entry in this archive was researched, verified, and written by one person — for free. No corporate funding. No ad revenue. Just a developer who believes verified history should be accessible to everyone. Your donation directly funds new entries.
Crypto accepted · No subscription required
← Previous
Formally launched the Water, Sanitation and Hygiene (WASH) initiative as a dedicated Gates Foundation program
Next →
Backed household water treatment technologies — ceramic filters, chlorination, and safe storage for rural communities
[CROSS_REFERENCES] · grep --category='Global Health'
Related Accomplishments
January 2026
Gates-backed World Mosquito Program reaches 16 million people protected from dengue via Wolbachia method
The World Mosquito Program — backed in part by the Gates Foundation — announced in January 2026 that its Wolbachia-infected mosquito releases had reached over 16.1 million people across multiple countries, including Colombia, Indonesia, Brazil, Sri Lanka, Fiji, Vanuatu, and Vietnam. Wolbachia-carrying Aedes aegypti mosquitoes — which block dengue, Zika, chikungunya, and yellow fever transmission — had established self-sustaining populations in treated cities without requiring ongoing releases. Gold-standard randomised trials in Indonesia showed a 77% reduction in dengue incidence. The program represented one of the largest and most cost-effective vector control deployments in history.
2025
Gates-Funded Monoclonal Antibody Shows Early Promise as a Single-Shot Malaria Shield
[ARCHIVE_FUNDING] · INDEPENDENT · NO ADS
One developer. >300 verified entries. Zero ads. Forever free.
No sponsors, no paywall, no algorithm. If this archive has been useful to you, reader support is what keeps it running.